GrouseMan wrote:DK - Thanks for this - I took a look at the site today attempting to locate a few options for my wife, now that she has failed her first trial (Iri, Erbitux and Avastin) A 20% growth (4 to 6 mm) in 2 of them over a period of 9 months which is the criteria for failure. They were small to begin with. I see a few trials you list I may attempt to investigate further. She is MSS-CRC and all mets other than the ones in her abdomen are stable and under control (calcified or gone). She only has 4 or 5 I think she said and the biggest is pressing against her ureter between kidney and bladder. They are not all that big yet. Any trials on your priority list?
Regards,
GrouseMan
Hi GrouseMan-
Sorry to hear about your wife's progression on her past trial, I sincerely hope the trial finder can help you find the next trial. It is heavily biased towards immunotherapy trials, so just a repeat that it does not show every possible CRC trial out there.
"In general" (purely as scientific educated guess - I don't have a crystal ball to tell the future in general or what trial will work for a particular patient), since MSS-CRC is so immunologically cold, I am currently leaning towards trials: that are either 1.) more "brute force" and less impacted by a cold tumor environment (like some of the bifunctional trials) and 2.) trials that actively via MoA try to convert cold MSS-CRC tumors into hot tumors prior to PD1 inhibitor therapy. That is the mechanistic basis for the trial I signed up for myself ( NCT02636036) - which is designed to use an oncolytic virus to heat up a tumor and then hit it with a PD1 inhibitor (and this trial has a site near you in Detroit), As I posted about previously, I also am intrigued by the published Phase 1 results of the repurposed AIDS-drug Maraviroc - although that would need to be tried (under the supervision of your oncologist!!) via off-label use since there is not currently a CCR5 antagonist inhibitor trial running in the US.
All the best to you and your wife,
-DK